Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanne Andersen

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Science Translational Medicine|January 25, 2022
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humansYueh-Ming Loo, Patrick M McTamney, Rosalinda H Arends, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Vaccine Protection Against the SARS-CoV-2 Omicron Variant in MacaquesAbishek Chandrashekar, Jingyou Yu, Katherine McMahan, et al.
NPJ Vaccines|January 11, 2022
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamstersLisa H Tostanoski, Abishek Chandrashekar, Shivani Patel, et al.
Science (New York, N.Y.)|October 7, 2016
Rapid development of a DNA vaccine for Zika virusKimberly A Dowd, Sung-Youl Ko, Kaitlyn M Morabito, et al.
Biorxiv : the Preprint Server for Biology|July 20, 2021
A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primatesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Science Translational Medicine|November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infectionChristopher D Petro, Andrea T Hooper, Avery Peace, et al.
Nature|June 23, 2021
Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaquesJingyou Yu, Lisa H Tostanoski, Noe B Mercado, et al.
Nature|February 3, 2017
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNorbert Pardi, Michael J Hogan, Rebecca S Pelc, et al.
Immunity|August 19, 2025
Immunopathogenesis of lethal H5N1 avian influenza virus clade 2.3.4.4b infection in macaquesHanne Andersen, Malika Aid, Jonathan J Stone, et al.
Cell Reports. Medicine|April 6, 2023
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaquesJingyou Yu, Paul V Thomas, Michaela Sciacca, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Science Translational Medicine|January 25, 2022
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humansYueh-Ming Loo, Patrick M McTamney, Rosalinda H Arends, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Vaccine Protection Against the SARS-CoV-2 Omicron Variant in MacaquesAbishek Chandrashekar, Jingyou Yu, Katherine McMahan, et al.
NPJ Vaccines|January 11, 2022
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamstersLisa H Tostanoski, Abishek Chandrashekar, Shivani Patel, et al.
Science (New York, N.Y.)|October 7, 2016
Rapid development of a DNA vaccine for Zika virusKimberly A Dowd, Sung-Youl Ko, Kaitlyn M Morabito, et al.
Biorxiv : the Preprint Server for Biology|July 20, 2021
A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primatesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Science Translational Medicine|November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infectionChristopher D Petro, Andrea T Hooper, Avery Peace, et al.
Nature|June 23, 2021
Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaquesJingyou Yu, Lisa H Tostanoski, Noe B Mercado, et al.
Nature|February 3, 2017
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNorbert Pardi, Michael J Hogan, Rebecca S Pelc, et al.
Immunity|August 19, 2025
Immunopathogenesis of lethal H5N1 avian influenza virus clade 2.3.4.4b infection in macaquesHanne Andersen, Malika Aid, Jonathan J Stone, et al.
Cell Reports. Medicine|April 6, 2023
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaquesJingyou Yu, Paul V Thomas, Michaela Sciacca, et al.
Pageof 14